Activin a antibody formulations and methods of use thereof

MYPI2025006729A0Undetermined Publication Date: 2021-12-18REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025006729
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-06-18
Filing Date
2021-06-18
Publication Date
2021-12-18
Patent Text Reader

Abstract

The present invention provides novel pharmaceutical formulations comprising an antibody that specifically binds to human Activin A. The formulations may contain, in addition to an anti Activin A antibody, a histidine buffer, an organic cosolvent, and a thermal stabilizer. The pharmaceutical formulations of the present invention exhibit a surprising degree of antibody stability after storage for several months and after being subjected to thermal and other physical stress. No suitable figure.
Need to check novelty before this filing date? Find Prior Art